The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2021

Filed:

Sep. 15, 2017
Applicant:

Leukocare Ag, Martinsried, DE;

Inventors:

Kristina Kemter, Garching bei München, DE;

Martin Scholz, Munich, DE;

Assignee:

Leukocare AG, Martinsried, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 47/00 (2006.01); A61K 47/26 (2006.01); C12N 7/00 (2006.01); A61K 9/19 (2006.01); A61K 39/39 (2006.01); A61K 47/18 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/19 (2013.01); A61K 39/39 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); C12N 7/00 (2013.01); A61K 39/00 (2013.01); C12N 2710/10023 (2013.01); C12N 2710/10034 (2013.01); C12N 2710/10043 (2013.01); C12N 2710/10051 (2013.01);
Abstract

The present invention relates to a method for preparing viral vector-based compositions wherein the viral vector-based particles present in the composition have a particle size distribution with a polydispersity index (PDI) of less than 0.5, the method comprising the steps: (a) providing replication-deficient viral vectors; (b) providing a solution comprising at least one sugar and at least three different excipients selected from hydrophilic and amphiphilic excipients, wherein the excipients are characterized by polar, aliphatic, aromatic, negatively charged, and/or positively charged functional groups, and wherein the solution is further characterized by an excipient-sugar ratio of at least 1:2 (w/w); and (c) mixing the replication deficient viral vectors of step (a) with the solution of step (b). The present invention further relates to a viral vector-based composition obtainable by the method of the invention as well as to the viral vector-based composition of the invention for use as a prime-boost vaccine.


Find Patent Forward Citations

Loading…